Episurf Medical AB (publ) (EPIS-B) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.244x

Based on the latest financial reports, Episurf Medical AB (publ) (EPIS-B) has a cash flow conversion efficiency ratio of -0.244x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-11.60 Million ≈ $-1.25 Million USD) by net assets (Skr47.50 Million ≈ $5.11 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see EPIS-B company net worth for the company's overall valuation and market capitalisation.

Episurf Medical AB (publ) - Cash Flow Conversion Efficiency Trend (2010–2025)

This chart illustrates how Episurf Medical AB (publ)'s cash flow conversion efficiency has evolved over time, based on yearly financial data.

Episurf Medical AB (publ) Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Episurf Medical AB (publ) ranked by their cash flow conversion efficiency. See EPIS-B cash flow to debt ratio to evaluate how effectively operating cash flow covers total debt obligations.

Company Cash Flow Conversion Efficiency
MSCM Holdings Bhd
KLSE:0041
-0.048x
Bina Darulaman Bhd
KLSE:6173
-0.031x
Jocil Limited
NSE:JOCIL
-0.200x
Quantum Software SA
WAR:QNT
0.009x
Coral India Finance & Housing Limited
NSE:CORALFINAC
0.048x
TCS Group Holdings Bhd
KLSE:0221
-0.150x
AztechWB Co. Ltd
KQ:032080
0.002x
Artroniq Berhad
KLSE:0038
0.001x

Annual Cash Flow Conversion Efficiency for Episurf Medical AB (publ) (2010–2025)

The table below shows the annual cash flow conversion efficiency of Episurf Medical AB (publ) from 2010 to 2025. View Episurf Medical AB (publ) stock quote for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 Skr47.50 Million
≈ $5.11 Million
Skr-55.30 Million
≈ $-5.95 Million
-1.164x -36.64%
2024-12-31 Skr83.80 Million
≈ $9.02 Million
Skr-71.40 Million
≈ $-7.68 Million
-0.852x +15.10%
2023-12-31 Skr84.50 Million
≈ $9.09 Million
Skr-84.80 Million
≈ $-9.13 Million
-1.004x -156.59%
2022-12-31 Skr177.70 Million
≈ $19.12 Million
Skr-69.50 Million
≈ $-7.48 Million
-0.391x -65.62%
2021-12-31 Skr252.80 Million
≈ $27.21 Million
Skr-59.70 Million
≈ $-6.42 Million
-0.236x +26.01%
2020-12-31 Skr169.50 Million
≈ $18.24 Million
Skr-54.10 Million
≈ $-5.82 Million
-0.319x +77.68%
2019-12-31 Skr41.40 Million
≈ $4.46 Million
Skr-59.20 Million
≈ $-6.37 Million
-1.430x -22.49%
2018-12-31 Skr44.80 Million
≈ $4.82 Million
Skr-52.30 Million
≈ $-5.63 Million
-1.167x -62.75%
2017-12-31 Skr85.57 Million
≈ $9.21 Million
Skr-61.38 Million
≈ $-6.61 Million
-0.717x +37.73%
2016-12-31 Skr48.70 Million
≈ $5.24 Million
Skr-56.10 Million
≈ $-6.04 Million
-1.152x -232.91%
2015-12-31 Skr109.93 Million
≈ $11.83 Million
Skr-38.04 Million
≈ $-4.09 Million
-0.346x +57.54%
2014-12-31 Skr38.85 Million
≈ $4.18 Million
Skr-31.66 Million
≈ $-3.41 Million
-0.815x -182.71%
2013-12-31 Skr71.61 Million
≈ $7.71 Million
Skr-20.64 Million
≈ $-2.22 Million
-0.288x +53.27%
2012-12-31 Skr24.39 Million
≈ $2.62 Million
Skr-15.05 Million
≈ $-1.62 Million
-0.617x -664.38%
2011-12-31 Skr48.50 Million
≈ $5.22 Million
Skr-3.91 Million
≈ $-421.19K
-0.081x +60.69%
2010-12-31 Skr9.74 Million
≈ $1.05 Million
Skr-2.00 Million
≈ $-215.09K
-0.205x --

About Episurf Medical AB (publ)

ST:EPIS-B Sweden Medical Devices
Market Cap
$14.11 Million
Skr131.08 Million SEK
Market Cap Rank
#26256 Global
#541 in Sweden
Share Price
Skr0.08
Change (1 day)
+11.11%
52-Week Range
Skr0.03 - Skr0.20
All Time High
Skr22.30
About

Episurf Medical AB (publ), a medical device company, designs and manufactures implants and surgical instruments in Germany, Sweden, rest of Europe, the United States, and internationally. It offers Episealer Knee for repairing focal cartilage and bone defects to reduce pain and increase mobility in the patient's knee joint; Episealer implant, which is designed to fit anatomy and size of the lesio… Read more